BioSpace News Archive

NanoVibronix, Inc. announced that, on August 30, 2022, the Company received notice from the Nasdaq Listing Qualifications Staff indicating that, based upon the Company’s continued non-compliance with Nasdaq’s minimum bid price requirement as of August 29, 2022, the Company securities would be subject to delisting unless the Company timely requests a hearing before the Nasdaq Hearings Panel.

Kezar Life Sciences, Inc. announced that the Compensation Committee of the company’s Board of Directors granted one employee a nonqualified stock option to purchase 18,000 shares of its common stock with an exercise price of $10.10 per share, which is equal to the closing price of Kezar’s common stock on September 1, 2022, the grant date of the award.

Oxurion NV announced that it has amended its mandatory convertible bonds issuance and subscription agreement announced on April 6, 2021 with the Negma Group, a financial institution focused on supporting growth and capturing value through a multi-strategy approach.

Mirati Therapeutics, Inc., a clinical-stage targeted oncology company, announced that the company granted equity awards to 25 new employees with a grant date of September 1, 2022, as equity inducement awards outside of the company’s 2022 Equity Incentive Plan and material to the employees’ acceptance of employment with the company.

The latest market analysis report published by Reports and Data, titled ‘Global Doose Syndrome Treatment Market – Forecast to 2030,’ thoroughly examines the Doose Syndrome Treatment industry to provide essential data & information for the targeted readers.

The latest market analysis report published by Reports and Data, titled ‘Global Primary Biliary Cirrhosis Market – Forecast to 2030,’ thoroughly examines the Primary Biliary Cirrhosis industry to provide essential data & information for the targeted readers.

The latest market analysis report published by Reports and Data, titled ‘Global Prurigo Nodularis Market – Forecast to 2030,’ thoroughly examines the Prurigo Nodularis industry to provide essential data & information for the targeted readers.

The latest market analysis report published by Reports and Data, titled ‘Global Thyroid Eye Disease Market – Forecast to 2030,’ thoroughly examines the Thyroid Eye Disease industry to provide essential data & information for the targeted readers.

The cell culture media market has been projected to expand at a noteworthy pace throughout the forecast period.

The latest market analysis report published by Reports and Data, titled ‘Global Scleroderma Market – Forecast to 2030,’ thoroughly examines the Scleroderma industry to provide essential data & information for the targeted readers.